Cullen/Frost Bankers, Inc. Abiomed Inc Transaction History

Cullen/Frost Bankers, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$242.49 - $301.46 $484 - $602	2 Added 1.0%	202 $50,000
Q3 2021 Nov 04, 2021	SELL	$310.19 - $376.2 $3,722 - $4,514	-12 Reduced 5.66%	200 $65,000
Q2 2021 Aug 05, 2021	BUY	$262.71 - $351.17 $3,152 - $4,214	12 Added 6.0%	212 $66,000
Q1 2020 May 01, 2020	SELL	$130.51 - $196.01 $9,657 - $14,504	-74 Reduced 27.01%	200 $29,000
Q4 2019 Feb 06, 2020	BUY	$159.31 - $223.54 $43,650 - $61,249	274 New	274 $47,000
Q3 2019 Nov 01, 2019	SELL	$175.89 - $279.23 $52,766 - $83,769	-300 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$276.39 - $362.25 $82,917 - $108,675	300 New	300 $86,000
Q4 2018 Feb 06, 2019	SELL	$281.08 - $444.25 $250,161 - $395,382	-890 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$354.53 - $449.75 $52,470 - $66,563	-148 Reduced 14.26%	890 $400,000
Q2 2018 Jul 27, 2018	BUY	$278.07 - $446.21 $288,636 - $463,165	1,038 New	1,038 $425,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.